7 completed, 2 unknown, 1 withdrawn. 10 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 7, Unknown 2, Withdrawn 1 |
| Phase 1 | 2 | Completed 2 |
Follow Elimination Disorders: new trials by email Literature Review of Elimination Disorders trials Research Report on Elimination Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Eluxadoline (Viberzi®) 100 mg Twice Daily on Diarrhea-Associated Fecal Incontinence Eluxadoline 100 mg, Placebo - Fecal Incontinence, Accidental Bowel Leakage | Phase 2 | Withdrawn | University of North Carolina, Chapel Hill | 2019-04-01 | 2019-07-25 | |
| Methylene Blue Against Falciparum Malaria in Burkina Faso Methylene Blue, Primaquine - Malaria, Falciparum | Phase 2 | Completed | Heidelberg University | 100 | 2016-10-01 | 2020-03-25 |
| Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence Infusion of mesenchymal stem cells from adipose tissue, Infusion of placebo - Faecal Incontinence | Phase 1 / Phase 2 | Completed | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 16 | 2013-10-01 | 2018-04-17 |
| Autologous Cell Therapy for Treatment of Fecal Incontinence Iltamiocel - Fecal Incontinence | Phase 1 / Phase 2 | Completed | Cook MyoSite | 53 | 2013-03-28 | 2024-02-16 |
| A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period 1R, 2S-methoxamine hydrochloride, Placebo - Faecal Incontinence | Phase 2 | Completed | Norgine | 417 | 2012-02-01 | 2015-06-09 |
| The Effect of Melatonin on Nocturnal Enuresis Melatonin, Lactose - Nocturnal Enuresis | Phase 2 | Unknown | University of Aarhus | 40 | 2012-01-01 | 2012-11-02 |
| Efficacy of Functional Magnetic Stimulation in Urinary Incontinence FMS (Magstim rapid2) - Incontinence | Phase 2 | Unknown | vghtpe user | 40 | 2010-11-01 | 2014-03-19 |
| Translating Unique Learning for Incontinence Prevention Instructional DVD, Bladder Health Class - Urinary Incontinence | Phase 2 | Completed | University of Michigan | 647 | 2010-09-01 | 2016-05-12 |
| Family Help Program: Nighttime Enuresis Treatment Program FHP Night time ENuresis Intervention - Enuresis | Phase 2 | Completed | IWK Health Centre | 56 | 2003-06-01 | 2016-09-02 |
| A Study to Determine if Ibuprofen in Combination With Pseudoephedrine HCl is More Effective Than Each Drug Alone in the Treatment of Nighttime Bedwetting ibuprofen; pseudoephedrine HCl - Enuresis | Phase 2 | Completed | Johnson & Johnson Consumer and Personal Products Worldwide | 318 | 2011-06-29 |
Encopresis (4) · Nocturnal Enuresis (4) · Enuresis (3) · Fecal Incontinence (2) · Urinary Incontinence (2) · Urinary Incontinence, Urge (2) · Diarrhea (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Malaria, Falciparum (1) · Motor Activity (1) · Rectal Diseases (1) · Urinary Bladder, Overactive (1) · Urinary Incontinence, Stress (1)
Mental Disorders (10) · Behavior (9) · Behavioral Symptoms (9) · Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Male Urogenital Diseases (7) · Urination Disorders (7) · Urogenital Diseases (7) · Urologic Diseases (7) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Signs and Symptoms, Digestive (4) · Lower Urinary Tract Symptoms (3) · Urological Manifestations (3)
Ibuprofen (1) · Lactose (1) · Melatonin (1) · Methylene Blue (1) · Primaquine (1) · Pseudoephedrine (1) · Sugars (1) · eluxadoline (1)
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud (1) · Cook MyoSite (1) · Heidelberg University (1) · IWK Health Centre (1) · Johnson & Johnson Consumer and Personal Products Worldwide (1) · Norgine (1) · University of Aarhus (1) · University of Michigan (1) · University of North Carolina, Chapel Hill (1) · vghtpe user (1)
Canada (2) · Spain (2) · United Kingdom (2) · Burkina Faso (1) · Czechia (1) · Denmark (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Poland (1) · Sweden (1) · Taiwan (1) · United States (1)
Carolyn Sampselle, PHD, RN (1) · Fernando de la Portilla, Dr. (1) · Laurent Siproudhis, MD (1) · Manoj J Raval, MD (1) · Patrick J. McGrath, PhD. (1) · Po-Yi Tsai, MD (1) · Santiago Mera, Dr. (1)
PMID 32364251, PMID 17227604, PMID 18025870, PMID 25073008, PMID 31600221, PMID 37144409
R01NR012011 (1)